+34 93 402 04 56 info@proteodesign.es

ProteoDesign is a member of the INPACT Consortium, which has recently been awarded a Research and Innovation Staff Exchange (RISE) grant by the European Commission.

The INPACT (Innovative Peptides Against Cancer and Pathogenic Bacteria) project aims to develop a platform technology to produce innovative peptide based drugs. The Consortium is lead by the Instituto de Medicina Molecular (Lisbon, Portugal) and includes participants from academia and industry from Spain (Universitat Pompeu Fabra, ProteoDesign, CEAMED, IESE), Portugal (IMM, TechnoPhage), USA (Stanford University), Brasil (Federal University of Rio de Janeiro, Ciencia Hoje) and Australia (University of Queensland).